Delayed energy protection of ischemic preconditioning on hepatic ischemia/reperfusion injury in rats

European Surgical Research

Volumn 38, Issue 2, 2006, Pages 114-121

  Ofluoglu, E ^a   Kerem, M ^a   Pasaoglu, H ^a   Turkozkan, N ^a   Seven, I ^a   Bedirli, A ^a   Utku Yilmaz, T ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Arginase; Energy charge; Ischemic preconditioning; Liver; Malondialdehyde; Nitric oxide

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; ARGINASE; MALONALDEHYDE; NITRATE; NITRITE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ISCHEMIC PRECONDITIONING; LIVER INJURY; LIVER ISCHEMIA; LIVER NECROSIS; LIVER PROTECTION; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RAT; REPERFUSION INJURY; TIME;

ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALANINE TRANSAMINASE; ANIMALS; ARGINASE; ENERGY METABOLISM; ISCHEMIC PRECONDITIONING; LIVER; MALE; MALONDIALDEHYDE; NECROSIS; NITRATES; NITRITES; RATS; RATS, WISTAR; REPERFUSION INJURY; TIME FACTORS;

EID: 33745026068     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093300     Document Type: Article

References (34)

1. Makuuchi M, Mori T, Gunven P, et al: Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet 1987;164:155-158.
2. Serracino-Inglott F, Habib NA, Mathie RT: Hepatic ischemia-reperfusion injury. Am J Surg 2001;181:160-166.
3. Palombo JD, Pomposelli JJ, Hirschberg Y, et al: Glycolytic support of adenine nucleotides in rat liver flush-preserved with UW or Collins' II. Importance of donor nutritional status. Transplantation 1989;48:901-905.
4. Lanir A, Jenkins RL, Caldwell C, et al: Hepatic transplantation survival: correlation with adenine nucleotide level in donor liver. Hepatology 1988;8:471-475.
5. Murry C, Jennings R, Reimer K: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
6. Korthuis R, Gute D, Cepinskas G, Kvietys P: Cellular mechanisms of acute versus delayed preconditioning. Pathophysiology 1998;5:35-48.
7. Cutrin JC, Perrelli MG, Cavalieri B, et al: Microvascular dysfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radic Biol Med 2002;33:1200-1208.
8. Selzner N, Selzner M, Jochum W, Clavien PA: Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP-dependent mechanism. J Hepatol 2003;39:55-61.
9. Peralta C, Bartrons R, Riera L, et al: Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol 2000;279:G163-G171.
10. Clavien PA, Selzner M, Rudiger HA, et al: A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003;238:843-852.
11. Ilhan A, Akyol O, Gurel A, et al: Protective effects of caffeic acid phenethyl ester against experimental allergic encephalomyelitis induced oxidative stress in rats. Free Radic Biol Med 2004;37:386-394.
12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurements with the folin phenol reagent. J Biol Chem 1951;193:265-275.
13. Geyer JW, Dabich D: Rapid method for determination of arginase activity in tissue homogenates. Anal Biochem 1971;39:412-417.
14. Pasaoglu H, Bulduk G, Ogus E, Pasaoglu A, Onalan G: Nitric oxide, lipid peroxides, and uric acid levels in pre-eclampsia and eclampsia. Tohoku J Exp Med 2004;202:87-92.
15. Smarason AK, Allman KG, Young D, Redman CW: Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with preeclampsia. Br J Obstet Gynaecol 1997;104;538-43.
16. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
17. Szabo C, Saunders C, O'Connor M, Salzman AL: Peroxynitrite causes energy depletion and increases permeability via activation of poly (ADP-ribose) synthetase in pulmonary epithelial cells. Am J Respir Cell Mol Biol 1997;16:105-109.
18. Yadav S, Sindram D, Perry D, Clavien PA: Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 1999;30:1223-1231.
19. Scommotau S, Uhlmann D, Loffler BM, Breu V, Spiegel HU: Involvement of endothelin/nitric oxide balance in hepatic ischemia/reperfusion injury. Langenbecks Arch Surg 1999;384:65-70.
20. Kawada N, Tran-Thi TA, Klein H, Decker K: The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 1993;213:815-823.
21. Bedirli A, Kerem M, Pasaoglu H, et al: Effects of ischemic preconditioning on regenerative capacity of hepatocyte in the ischemically damaged liver. J Surg Res 2005;125:42-48.
22. Gotoh T, Sonoki T, Nagasaki A, Terada K, Takiguchi M, Mori M: Molecular cloning of cDNA for non-hepatic arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line. FEBS Lett 1996;395:119-122.
23. Ikemoto M, Tsunekawa S, Toda Y, Totani M: Liver-type arginase is a highly sensitive marker for hepatocellular damage in rats. Clin Chem 2001;47;46-48.
24. Prins HA, Meijer C, Nijveldt RJ, Wiezer MJ, van Leeuwen PA: High plasma levels of arginine and liver arginase in Kupffer-cell-depleted rats after partial hepatectomy. J Hepatol 2000;32:399-405.
25. Boucher JL, Moali C, Tenu JP: Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci 1999;55:1015-1028.
26. G-hydroxy-l-arginine during high-output NO production. Am J Physiol 1996;271:1988-1998.
27. Gotoh T, Mori M: Arginase II down-regulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells. J Cell Biol 1999;144:427-434.
28. Chang CI, Liao JC, Kuo L: Arginase modulates nitric oxide production in activated macrophages. Am J Physiol 1998;274:342-348.
29. Lochner A, Marais E, Du Toit E, Moolman J: Nitric oxide triggers classic ischemic preconditioning. Ann NY Acad Sci 2002;962:402-414.
30. Serracino-Inglott F, Virlos IT, Habib NA, et al: Adenosine preconditioning attenuates hepatic reperfusion injury in the rat by preventing the down-regulation of endothelial nitric oxide synthase. BMC Gastroenterol 2002;2:22.
31. Gong JP, Tu B, Wang W, et al: Protective effect of nitric oxide induced by ischemic preconditioning on reperfusion injury of rat liver graft. World J Gastroenterol 2004;10:73-76.
32. Peralta C, Closa D, Hotter G, et al: Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun 1996;229:264-270.
33. Ilhan N, Halifeoglu I, Ozercan HI, Ilhan N: Tissue malondialdehyde and adenosine triphosphate level after experimental liver ischemia-reperfusion damage. Cell Biochem Funct 2001;19:207-212.
34. Murry CE, Richard VJ, Reimer KA, Jennings RB: Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990;66:913-931.